ArticleInternational journal of molecular sciences2024

Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.

Demond Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.